Full Text View
Tabular View
No Study Results Posted
Related Studies
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
This study has been completed.
Study NCT00167167   Information provided by Masonic Cancer Center, University of Minnesota
First Received: September 9, 2005   Last Updated: July 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia, Myeloid, Chronic
AML
MDS
Leukemia, Lymphocytic, Acute
Additional conditions recognized in this trial
Leukemia
Leukemia, Lymphoid
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Myeloproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Donor Lymphocyte Infusion
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services